|
BGLC BioNexus Gene Lab Corp 1737523 |
| Balance Sheet |
|
Current Assets
|
$4,943,409.00 |
|
Assets
|
$8,726,423.00 |
|
Current Liabilities
|
$812,938.00 |
|
Liabilities
|
$947,981.00 |
|
Equity
|
$7,778,442.00 |
|
Shares Out
|
2417314.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-570,162.00 |
|
Investing Cash Flow
|
$402,152.00 |
| Market Analysis |
Market Cap
|
$3,843,529.26 |
|
Price
|
$1.59 |
|
BVPS
|
3.22 |
|
PB
|
0.49 |
|
EPS
|
-0.12 |
|
PS
|
12.62 |
|
FCF
|
$-570,737.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:02 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:52 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BGLC documents filed with the SEC.
BGLC Filings
Clear
